Presentation of verification materials for iPS cell culture: Simultaneous measurement and analysis of up to 16 items in 4 minutes and 30 seconds! Strong support for improving culture efficiency.
There is data indicating that "an appropriate culture medium environment correlates with an increase in cell numbers," which necessitates the creation and adjustment of an appropriate culture medium environment to promote efficient cell culture. Are you unable to execute this due to the "time required for measurement and analysis" being a bottleneck? The cell culture environment automatic analysis device 'BioProfile FLEX2' can analyze the components of cell culture media for up to 16 items in just 4.5 minutes. It allows for rapid quantification of culture conditions such as metabolism, proliferation, and differentiation, contributing to the establishment of a culture environment aimed at mass production. ★ We are currently offering materials that investigate the correlation between changes in medium components and cell numbers in iPS cell culture. 【Features】 ■ Simultaneous analysis of up to 16 items ■ Rapid measurement time: as short as 2 minutes, up to 4 minutes and 30 seconds (depending on measurement items) ■ Capable of measuring consumption and production rates of major metabolites ■ Compatible with multiple shapes of sample containers ■ Equipped with an auto-sampling function for continuous measurement of samples *For more details, please refer to the materials available for download in PDF format.
Inquire About This Product
basic information
【Product Specifications】 Analysis Items: Glucose/Lactate/Glutamine/Glutamic Acid/NH4+/Na+/K+ Ca++/pH/pO2/pCO2/Total Cell Density/Viable Cell Density/Viability/Cell Diameter/Osmotic Pressure Automatic Calibration: 2 hours (fixed)/Time required 2 minutes Operating Environment: Temperature 10–30℃ Humidity 20–85% *For more details, please refer to the materials available for download in PDF format.
Price range
Delivery Time
Applications/Examples of results
【Application Examples】 ■ Non-invasive measurement of cell proliferation based on glucose consumption and lactate production ■ Optimization of layered culture conditions based on glucose consumption and ammonia production ■ Removal of undifferentiated stem cells and purification of tissue-differentiated cells through medium component adjustment ■ The role of iPS cell survival and glutamine metabolism *For more details, please refer to the PDF document or feel free to contact us.
catalog(9)
Download All Catalogs
![[Verification Material] The Importance of Analyzing Culture Medium Components in iPS Cell Cultivation](https://image.mono.ipros.com/public/catalog/image/01/38c/440458/IPROS56142213031488853103.jpeg?w=120&h=170)
![[Verification Material] Study on Quality Control through Parameter Measurement in iPS Cell Culture Supernatant](https://image.mono.ipros.com/public/catalog/image/01/60f/493367/IPROS23718073658714076613.jpeg?w=120&h=170)
![[User Report] Measurement of Immune Cell Metabolic State and Optimization of Culture Environment (Dr. Toshihisa Mikami, Regcell Inc.)](https://image.mono.ipros.com/public/catalog/image/01/3a2/572403/IPROS48483979607369921339.jpeg?w=120&h=170)
News about this product(9)
Company information
Nova Biomedical Corporation is a bio-medical company headquartered in Boston, USA. Since the development of the ionized calcium sensor in 1978, we have successfully commercialized innovative biosensors and have been providing innovative products that reflect the needs of medical settings and clinical research fields to this day. Our "automated analysis system for cell culture environments" supports research in fields such as "regenerative medicine" and "gene drug discovery." In the fortunate environment known as "Boston Bio Valley," we leverage cutting-edge science and technology to deliver better products to doctors, nurses, technicians, and researchers, continuously challenging ourselves to innovate. We have provided innovative products that reflect the needs of medical settings up to the present day. We will continue to support healthcare professionals and researchers to provide solutions as quickly as possible to patients suffering from difficult diseases. Our company has over 1,000 employees, with sales and service subsidiaries in eight countries and distributors in more than 90 countries. Nova Biomedical's products are being adopted worldwide.